Literature DB >> 31626839

In vitro cytotoxicity of Clinacanthus nutans fractions on breast cancer cells and molecular docking study of sulphur containing compounds against caspase-3.

Roziasyahira Mutazah1, Hazrulrizawati Abd Hamid2, Aizi Nor Mazila Ramli1, Mohd Fadhlizil Fasihi Mohd Aluwi1, Mashitah M Yusoff1.   

Abstract

Clinacanthus nutans has attracted Malaysian public interest due to its high medicinal value in the prevention of cancer. Currently, the specific compound or compounds giving rise to the anticancer potential of C. nutans has not been investigated thoroughly. The extraction was carried out by MeOH at room temperature using the powdered bark of C. nutans, while chromatography was carried out on a silica gel RP-18 column using the crude methanolic extract. Six fractions collected from column chromatography were evaluated by MTT assay against two breast cancer cell lines: MDA-MB-231 and MCF-7. Amongst the fractions, A12 and A17 were shown to exhibit the highest activity. Two sulphur-containing compounds, viz., entadamide C (1) and clinamide D (2), were isolated from these fractions. Molecular docking simulation studies revealed that entadamide C and clinamide D could bind favourably to the caspase-3 binding site with the binding energy of -4.28 kcal/mol and -4.84 kcal/mol, respectively. This study provides empirical evidence for the presence of sulphur-containing compounds in the leaves of C. nutans that displayed anticancer effects which explains its ethnomedicinal application against breast cancer. The docking simulation study showed that both compounds could serve as important templates for future drug design and development.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Caspase-3; Clinacanthus nutans; Cytotoxicity; MCF-7; MDA-MB-231; Molecular docking; Sulphur containing compounds

Mesh:

Substances:

Year:  2019        PMID: 31626839     DOI: 10.1016/j.fct.2019.110869

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  6 in total

Review 1.  Anti-Inflammatory Effects of Phytochemical Components of Clinacanthus nutans.

Authors:  Wei-Yi Ong; Deron R Herr; Grace Y Sun; Teng-Nan Lin
Journal:  Molecules       Date:  2022-06-04       Impact factor: 4.927

2.  Clinacanthus nutans Mitigates Neuronal Death and Reduces Ischemic Brain Injury: Role of NF-κB-driven IL-1β Transcription.

Authors:  Mei-Han Kao; Jui-Sheng Wu; Wai-Mui Cheung; Jin-Jer Chen; Grace Y Sun; Wei-Yi Ong; Deron R Herr; Teng-Nan Lin
Journal:  Neuromolecular Med       Date:  2020-10-06       Impact factor: 3.843

3.  Antioxidant Effects, Antiproliferative Effects, and Molecular Docking of Clinacanthus nutans Leaf Extracts.

Authors:  Noor Zafirah Ismail; Zaleha Md Toha; Musthahimah Muhamad; Nik Nur Syazni Nik Mohamed Kamal; Nur Nadhirah Mohamad Zain; Hasni Arsad
Journal:  Molecules       Date:  2020-04-29       Impact factor: 4.411

Review 4.  A Narrative Review on the Phytochemistry, Pharmacology and Therapeutic Potentials of Clinacanthus nutans (Burm. f.) Lindau Leaves as an Alternative Source of Future Medicine.

Authors:  Tan Yong Chia; Chee Yuen Gan; Vikneswaran Murugaiyah; Syed F Hashmi; Tabinda Fatima; Lazhari Ibrahim; Mohammed H Abdulla; Farhan Khashim Alswailmi; Edward James Johns; Ashfaq Ahmad
Journal:  Molecules       Date:  2021-12-27       Impact factor: 4.411

5.  Immunomodulatory potential of Clinacanthus nutans extracts in the co-culture of triple-negative breast cancer cells, MDA-MB-231, and THP-1 macrophages.

Authors:  Fariza Juliana Nordin; Lishantini Pearanpan; Kok Meng Chan; Endang Kumolosasi; Yoke Keong Yong; Khozirah Shaari; Nor Fadilah Rajab
Journal:  PLoS One       Date:  2021-08-11       Impact factor: 3.240

6.  Synthesis, characterization, molecular docking, and anticancer activities of new 1,3,4-oxadiazole-5-fluorocytosine hybrid derivatives.

Authors:  Az-Eddine El Mansouri; Saida Lachhab; Ali Oubella; Mehdi Ahmad; Johan Neyts; Dirk Jochmans; Winston Chiu; Laura Vangeel; Steven De Jonghe; Hamid Morjani; Mustapha Ait Ali; Mohamed Zahouily; Yogesh S Sanghvi; Hassan B Lazrek
Journal:  J Mol Struct       Date:  2022-09-09       Impact factor: 3.841

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.